GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.

An emerging hallmark of cancer is reprogrammed cellular metabolism, and several cancers involve increased glucose intake and glutamine addiction. Hepatocellular carcinoma (HCC) is one of the most fatal cancers, and its molecular basis needs to be delineated to identify biomarkers for its potential t...

Full description

Bibliographic Details
Main Authors:	Hong-Wei Sun, Xing-Juan Yu, Wen-Chao Wu, Jing Chen, Ming Shi, Limin Zheng, Jing Xu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5201247?pdf=render

Similar Items

BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1
by: Peng Wang, et al.
Published: (2023-12-01)

GLUT1 and ASCT2 Protein Expression in Papillary Thyroid Carcinoma Patients and Relation to Hepatitis C Virus: A Propensity-Score Matched Analysis
by: Ibrahiem AT, et al.
Published: (2022-03-01)

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy
by: Hai‐Long Chen, et al.
Published: (2018-11-01)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma.
by: Shi-Hong Zhang, et al.
Published: (2013-01-01)

Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
by: Xiao-Fei Zhang, et al.
Published: (2017-03-01)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
by: Jiali Wang, et al.
Published: (2022-01-01)

Nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy based on NADPH depletion
by: Congyi Zhang, et al.
Published: (2023-12-01)

CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
by: Li Li, et al.
Published: (2014-01-01)

Does GLUT-1 have a Role in Prognosis of Breast Carcinoma of Egyptian Patients?
by: Mohammed Abo El-Fotoh Shehata, et al.
Published: (2018-08-01)

Caspase polymorphisms and prognosis of hepatocellular carcinoma.
by: Song Zhang, et al.
Published: (2017-01-01)

Monocytes/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma
by: Ya-Ming Meng, et al.
Published: (2018-03-01)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
by: Yijun Luo, et al.
Published: (2020-05-01)

Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma.
by: Jing Chen, et al.
Published: (2014-01-01)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
by: Zaoqu Liu, et al.
Published: (2023-02-01)

Research Progress of Glutamine Transporter ASCT2 in Cancer
by: WANG Yale, et al.
Published: (2019-03-01)

Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation
by: Hai-Jing Yang, et al.
Published: (2016-12-01)

EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
by: Gang Xiao, et al.
Published: (2019-11-01)

Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma
by: Fernanda Rocha Rojas Ayala, et al.
Published: (2010-04-01)

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming
by: Guilin Nie, et al.
Published: (2023-02-01)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
by: Yang Chen, et al.
Published: (2023-04-01)

OPN and αvβ3 expression are predictors of disease severity and worse prognosis in hepatocellular carcinoma.
by: Yi Jin, et al.
Published: (2014-01-01)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma
by: Jia Fu, et al.
Published: (2015-10-01)

Prognosis of hepatocellular carcinoma metastasizing to the oral cavity
by: Jun-Hee Hong, et al.
Published: (2021-03-01)

The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
by: Shi-yi Wu, et al.
Published: (2022-06-01)

Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib
by: Fang Sun, et al.
Published: (2024-04-01)

C-Reactive Protein Is an Indicator of the Immunosuppressive Microenvironment Fostered by Myeloid Cells in Hepatocellular Carcinoma
by: Yongchun Wang, et al.
Published: (2022-01-01)

GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle
by: Aerni-Flessner Lauren, et al.
Published: (2012-06-01)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
by: Quanxiao Li, et al.
Published: (2021-06-01)

A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma
by: Yilin Tian, et al.
Published: (2022-09-01)

The potential value of CDV3 in the prognosis evaluation in Hepatocellular carcinoma
by: Heng Xiao, et al.
Published: (2018-06-01)

Primary Hepatocellular carcinoma: management and prognosis
by: Murtaza Mustafa, et al.
Published: (2016)

The Effects of GLUT1 on the Survival of Head and Neck Squamous Cell Carcinoma
by: Shengjiao Li, et al.
Published: (2013-09-01)

Corrigendum: C-reactive protein is an indicator of the immunosuppressive microenvironment fostered by myeloid cells in hepatocellular carcinoma
by: Yongchun Wang, et al.
Published: (2023-10-01)

Numb promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma.
by: Jian Wu, et al.
Published: (2014-01-01)

Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis
by: Jing-Yi Zhang, et al.
Published: (2017-01-01)

Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child–Pugh A
by: Jing Zhou, et al.
Published: (2022-08-01)

GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma
by: Sheng Zhang, et al.
Published: (2017-05-01)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
by: Hao Yang, et al.
Published: (2020-06-01)

Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database
by: Jingli Ding, et al.
Published: (2021-10-01)

GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma
by: Ting Liu, et al.
Published: (2017-06-01)